6Suppliers
13Customers
1Debt Items
20Related Chains

Source-Backed Evidence Depth

Bio-Rad Laboratories, Inc. (BIO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

21Total relationships
2Distinct source URLs
8High confidence
0.774Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Bio-Rad Laboratories, Inc. Suppliers

TickerNameConfidenceEvidence
HBIO Harvard Bioscience, Inc. 72% Reciprocal relationship from HBIO graph: nt, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Emka Technologies, Eppendorf AG, Hitachi, Instem plc, Kent Scientific Corp…
IMDX Insight Molecular Diagnostics Inc. 72% Reciprocal relationship from IMDX graph: Reciprocal relationship from BIO graph: Reciprocal relationship from IMDX graph: Reciprocal relationship from BIO graph: Reciprocal relationship from IMDX gra…
MXCT MaxCyte, Inc. 72% Reciprocal relationship from MXCT graph: doption of our products. If these KOLs, institutions and companies do not adopt our products for any reason, including those listed above, acceptance and adop…
QGEN Qiagen N.V. 72% Reciprocal relationship from QGEN graph: Reciprocal relationship from BIO graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from BIO graph: Reciprocal relationship from QGEN gra…
RNLXY Renalytix Plc 72% Reciprocal relationship from RNLXY graph: taining or establishing new laboratory space to support these commercialization and development efforts, or if our potential future ex-United States laborato…
DYN Dyne Therapeutics, Inc. 62% Reciprocal relationship from DYN graph: ation, compounding, or processing at a separate establishment outside the United States prior to being imported or offered for import into the United States. I…

Bio-Rad Laboratories, Inc. Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-AGRICULTURE USGOV-DEPARTMENT-OF-AGRICULTURE 95% USAspending awards from Department of Agriculture: $464,998 across 4 awards. 123A9423F0161 DELIVERY ORDER FOR IQ-CHECK KITS UNDER CONTRACT 123A9419D0001 WITH BIO-RAD LABORATORIES INC.; 123A9424F0026 …
USGOV-DEPARTMENT-OF-COMMERCE USGOV-DEPARTMENT-OF-COMMERCE 95% USAspending awards from Department of Commerce: $207,100 across 1 awards. 1333ND23PNB640547 BIORAD QX600 AUTODG DROPLET DIGITAL PCR SYSTEM | Qwen corrected direction: Explicit government contract awa…
USGOV-DEPARTMENT-OF-DEFENSE USGOV-DEPARTMENT-OF-DEFENSE 95% USAspending awards from Department of Defense: $171,511 across 1 awards. N6600125P6397 QX600 AUTODG DROPLET PCR SYSTEM | Qwen corrected direction: Explicit Department of Defense government contract a…
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES 95% USAspending awards from Department of Health and Human Services: $341,214 across 2 awards. 75D30124P19851 PURCHASE OF BIO-RAD OPUS INSTRUMENTS; 75N98019P03259 YEARLY SERVICE MAINTENANCE CONTRACT FOR …
USGOV-DEPARTMENT-OF-THE-INTERIOR USGOV-DEPARTMENT-OF-THE-INTERIOR 95% USAspending awards from Department of the Interior: $110,884 across 1 awards. 140D0426P0119 (1) BIO-RAD AUTOMATIC DROPLET GENERATOR (ADG S/N# 773BR3501) AND ONE (1) QX600 DROPLET READER | Qwen correc…
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS 95% USAspending awards from Department of Veterans Affairs: $396,950 across 1 awards. 36C26225P0701 IMMUNOLOGY | Qwen corrected direction: Explicit USAspending awards from Department of Veterans Affairs …
HBIO Harvard Bioscience, Inc. 72% Reciprocal relationship from HBIO graph: nt activities to advance our position in the industry as a provider of life science equipment, software and services. We plan to pursue a balanced development…
MXCT MaxCyte, Inc. 72% Reciprocal relationship from MXCT graph: doption of our products. If these KOLs, institutions and companies do not adopt our products for any reason, including those listed above, acceptance and adop…
ACQUISITIONS-STILLA-TECHNOLOGIES ACQUISITIONS-STILLA-TECHNOLOGIES 62% ome (loss). Warranty liabilities are included in Other current liabilities and Other long-term liabilities in the condensed consolidated balance sheets. Changes in our warranty liability for the thre…
CAPITAL-RESOURCES CAPITAL-RESOURCES 62% Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations This discussion should be read in conjunction with the information contained in both our consolidated fin…
SARTORIUS-AG SARTORIUS-AG 62% . Quality issues associated with components from these alternative sources may lead to product failures and associated costs notwithstanding our efforts to detect and remediate such quality issues. T…
SARTORIUS-HERBST-BETEILIGUNGEN-II-GMBH SARTORIUS-HERBST-BETEILIGUNGEN-II-GMBH 62% ts and integrations on an ongoing basis in order to effectively run our business. We may suffer interruptions in service, loss of data or reduced functionality when we upgrade or change systems or mi…
STILLA-TECHNOLOGIES STILLA-TECHNOLOGIES 62% ome (loss). Warranty liabilities are included in Other current liabilities and Other long-term liabilities in the condensed consolidated balance sheets. Changes in our warranty liability for the thre…

Bio-Rad Laboratories, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
BIO-DEBT Debt stack $1.4B 90% Market cache reports total debt of $1.4B.

Bio-Rad Laboratories, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Bio-Rad Laboratories, Inc..

Bio-Rad Laboratories, Inc. Ownership

HolderNameConfidenceEvidence
BIO-OWNER-FIRST-EAGLE-INVESTMENT-MANAGEMEN First Eagle Investment Management, LLC 90% 13F overlay lists First Eagle Investment Management, LLC as top holder; 395 tracked holders.

Bio-Rad Laboratories, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
TGTX TG Therapeutics, Inc. 100.00 2
TMO Thermo Fisher Scientific Inc. 100.00 2
JNJ Johnson & Johnson 100.00 2
BDX Becton, Dickinson and Company 100.00 2
HBIO Harvard Bioscience, Inc. 100.00 1 ['customer', 'supplier']
DYN Dyne Therapeutics, Inc. 100.00 1 ['supplier']
RNLXY Renalytix Plc 100.00 1 ['supplier']
QGEN Qiagen N.V. 100.00 1 ['supplier']
MXCT MaxCyte, Inc. 100.00 1 ['customer', 'supplier']
DTIL Precision BioSciences, Inc. 100.00 2
CELG-RI BRISTOL MYERS SQUIBB CO 50.00 2
ARWR Arrowhead Pharmaceuticals, Inc. 50.00 2
ELV Elevance Health, Inc. 50.00 2
ABT Abbott Laboratories 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
SRRK Scholar Rock Holding Corporation 50.00 2
CRS Carpenter Technology Corporation 50.00 2
TRDA Entrada Therapeutics, Inc. 50.00 2
ALNY Alnylam Pharmaceuticals, Inc. 50.00 2
MANU Manchester 50.00 2
🔐
BIO
Unlock BIO Supply Chain Data
Verified relationships include:
HBIOHarvard Bioscience, Inc.Supplier72%
IMDXInsight Molecular Diagnos…Supplier72%
USGOV-DEPARTMENT-OF-AGRICULTUREUSGOV-DEPARTMENT-OF-AGRICULTURECustomer95%
USGOV-DEPARTMENT-OF-COMMERCEUSGOV-DEPARTMENT-OF-COMMERCECustomer95%
+17 more relationships locked
Subscribe — View plans →